Optimization of a glycoengineered Pichia pastoris cultivation process for commercial antibody production

Glycoengineering enabled the production of proteins with human N‐linked glycans by Pichia pastoris. This study used a glycoengineered P. pastoris strain which is capable of producing humanized glycoprotein with terminal galactose for monoclonal antibody production. A design of experiments approach was used to optimize the process parameters. Followed by further optimization of the specific methanol feed rate, induction duration, and the initial induction biomass, the resulting process yielded up to 1.6 g/L of monoclonal antibody. This process was also scaled‐up to 1,200‐L scale, and the process profiles, productivity, and product quality were comparable with 30‐L scale. The successful scale‐up demonstrated that this glycoengineered P. pastoris fermentation process is a robust and commercially viable process. © 2011 American Institute of Chemical Engineers Biotechnol. Prog., 2011

[1]  C. Batt,et al.  High-level expression of a phage display-derived scFv in Pichia pastoris. , 2009, Methods in molecular biology.

[2]  J. Cregg,et al.  Expression in the yeast Pichia pastoris. , 2009, Methods in enzymology.

[3]  Marcus Taupp,et al.  Expression of recombinant proteins in the methylotrophic yeast Pichia pastoris. , 2010, Journal of visualized experiments : JoVE.

[4]  N. K. Khatri,et al.  Oxygen-limited control of methanol uptake for improved production of a single-chain antibody fragment with recombinant Pichia pastoris , 2006, Applied Microbiology and Biotechnology.

[5]  Jack Hoopes,et al.  Humanization of Yeast to Produce Complex Terminally Sialylated Glycoproteins , 2006, Science.

[6]  J. Cregg,et al.  Production of recombinant proteins in fermenter cultures of the yeast Pichia pastoris. , 2002, Current opinion in biotechnology.

[7]  T. Gerngross,et al.  Characterization of N-linked glycosylation on recombinant glycoproteins produced in Pichia pastoris using ESI-MS and MALDI-TOF. , 2009, Methods in molecular biology.

[8]  Youwei Jiang,et al.  Optimization of humanized IgGs in glycoengineered Pichia pastoris , 2006, Nature Biotechnology.

[9]  A. Apte-Deshpande,et al.  Efficient expression and secretion of recombinant human growth hormone in the methylotrophic yeast Pichia pastoris: potential applications for other proteins , 2009, Biotechnology and applied biochemistry.

[10]  Pingzuo Li,et al.  Expression of Recombinant Proteins in Pichia Pastoris , 2007, Applied biochemistry and biotechnology.

[11]  André M Deelder,et al.  IgG glycosylation analysis , 2009, Proteomics.

[12]  K. Kobayashi,et al.  High-level expression of recombinant human serum albumin from the methylotrophic yeast Pichia pastoris with minimal protease production and activation. , 2000, Journal of bioscience and bioengineering.

[13]  H. Tilbeurgh,et al.  Pichia pastoris is a valuable host for the expression of genes encoding membrane proteins from the hyperthermophilic Archeon Pyrococcus abyssi , 2007, Extremophiles.

[14]  Janice M Reichert,et al.  Monoclonal antibodies as innovative therapeutics. , 2008, Current pharmaceutical biotechnology.

[15]  Teresa Mitchell,et al.  Engineering of an artificial glycosylation pathway blocked in core oligosaccharide assembly in the yeast Pichia pastoris: production of complex humanized glycoproteins with terminal galactose. , 2004, Glycobiology.

[16]  P. Bobrowicz,et al.  High-throughput screening and selection of yeast cell lines expressing monoclonal antibodies , 2010, Journal of Industrial Microbiology & Biotechnology.

[17]  Joseph Shiloach,et al.  Effect of methanol feeding strategies on production and yield of recombinant mouse endostatin from Pichia pastoris. , 2003, Biotechnology and bioengineering.

[18]  T. Gerngross,et al.  Glycosylation engineering in yeast: the advent of fully humanized yeast. , 2007, Current opinion in biotechnology.

[19]  M. Inan,et al.  Rational design and optimization of fed-batch and continuous fermentations. , 2007, Methods in molecular biology.

[20]  Teresa Mitchell,et al.  Production of monoclonal antibodies by glycoengineered Pichia pastoris. , 2009, Journal of biotechnology.

[21]  Byung-Kwon Choi,et al.  Use of combinatorial genetic libraries to humanize N-linked glycosylation in the yeast Pichia pastoris , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Urs von Stockar,et al.  A quantitative analysis of the benefits of mixed feeds of sorbitol and methanol for the production of recombinant avidin with Pichia pastoris. , 2007, Journal of biotechnology.

[23]  Jing Li,et al.  Research and development of next generation of antibody-based therapeutics , 2010, Acta Pharmacologica Sinica.

[24]  B. Junker Scale-up methodologies for Escherichia coli and yeast fermentation processes. , 2004, Journal of bioscience and bioengineering.

[25]  Jianxin Ye,et al.  High‐level protein expression in scalable CHO transient transfection , 2009, Biotechnology and bioengineering.

[26]  N. K. Khatri,et al.  Impact of methanol concentration on secreted protein production in oxygen‐limited cultures of recombinant Pichia pastoris , 2006, Biotechnology and bioengineering.

[27]  Wenhui Zhang,et al.  Design of Methanol Feed Control in Pichia pastoris Fermentations Based upon a Growth Model , 2002, Biotechnology progress.

[28]  Huijuan Li,et al.  Purification process development of a recombinant monoclonal antibody expressed in glycoengineered Pichia pastoris. , 2011, Protein expression and purification.

[29]  Huijuan Li,et al.  Pharmacological significance of glycosylation in therapeutic proteins. , 2009, Current opinion in biotechnology.

[30]  Stephen G Oliver,et al.  Fed‐batch methanol feeding strategy for recombinant protein production by Pichia pastoris in the presence of co‐substrate sorbitol , 2009, Yeast.

[31]  G. Petsko Transformation , 2006, Genome Biology.

[32]  Thomas I Potgieter,et al.  Antibody expression kinetics in glycoengineered Pichia pastoris , 2010, Biotechnology and bioengineering.

[33]  A. Daugulis,et al.  A rational approach to improving productivity in recombinant Pichia pastoris fermentation. , 2001, Biotechnology and bioengineering.